Place of Origin: | Guangzhou, China |
---|---|
Brand Name: | Xinzhou |
Certification: | COA,GMP,CQC,SGS |
Model Number: | 1009119-65-6 |
Document: | Product Brochure PDF |
Minimum Order Quantity: | 1kg |
Price: | Negotiate |
Packaging Details: | 100g; 1kg; 25g |
Delivery Time: | 1-3 work days |
Payment Terms: | T/T advance, Bitcoin ,western union,Bank transfer |
Supply Ability: | 500kg per week |
Name: | Daclatasvir Dihydrochloride | CAS: | 1009119-65-6 |
---|---|---|---|
Molecular Formula: | C40H51ClN8O6 | Purity: | 99% |
Color: | White | Appearance: | Powder |
Package: | Aluminum Foil Bag And Carton Box | Molecular Weight: | 775.35 |
Meliting Point: | >207°C (dec.) | Storage: | -20°C Freezer |
Highlight: | Chemical Auxiliary Raw Materials,Auxiliary Raw Materials CAS 1009119-65-6,Daclatasvir Dihydrochloride Daclatasvir HCl |
Pharmaceutical Chemical Bulk Daclatasvir HCl Powder CAS 1009119-65-6
What is Daclatasvir hcl?
Daclatasvir Dihydrochloride is an anti-hepatitis C drug.
BMS-790052 is a highly selective inhibitor of HCV NS5A , for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture..
Function of Daclatasvir hcl
Daclatasvir Dihydrochloride is an anti-hepatitis C drug.
BMS-790052 is a highly selective inhibitor of HCV NS5A , for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture..
Application of Daclatasvir hcl
Daclatasvir Dihydrochloride is an anti-hepatitis C drug.
BMS-790052 is a highly selective inhibitor of HCV NS5A , for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. .
Daclatasvir Dihydrochloride , DAKLINZA. The form of dihydrochloride is used clinically. Bristol-Myers Squibb's new hepatitis C drug daclatasvir Dihydrochloride is the first potent NS5A replication complex inhibitor approved by the European Union and Japan. It is mainly used in combination with other drugs for all 1, 2Chemicalbook, 3, and 4 genotypes of chronic C Treatment of adult infected with hepatitis B (HCV). In addition, the safety of daclatasvir Dihydrochloride in the treatment of hepatitis C has been proven across various groups, including elderly patients, groups with advanced liver disease, recipient groups after liver transplantation, and HIV/HCV co-infected groups.
Product Name | Daclatasvir Dihydrochloride |
Purity | ≥99% |
Appearance | powder |
CAS NO. | 1009119-65-6 |
Molecular Formula | C40H51ClN8O6 |
Molecular Weight | 775.35 |
Meliting Point | >207°C (dec.) |
EINECS NO. | 816-965-3 |
Storage | -20°C Freezer |
Xingtai Xinzhou Technology Co., LTD.
Xingtai Xinzhou Technology Co., Ltd. was established in 2022 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures. Effectively promote the joint venture and cooperation with the major enterprises, manufacturers, with the idea of industrial development to serve the society and the majority of users. We always adhere to the market demand as the orientation, constantly synthesizing new high-tech chemical products and medical intermediates, mainly exported to the United States, India, South Africa, Nigeria and other countries and regions, has a wealth of export experience, to ensure transportation safety, can let each customer as soon as possible to safely receive the goods.